Literature DB >> 8082672

Technetium-99m methoxyisobutylisonitrile localizes an ectopic ACTH-producing tumour: case report and review of the literature.

H Jacobsson1, G Wallin, S Werner, S A Larsson.   

Abstract

Extensive investigation including whole-body examinations with computed tomography and magnetic resonance imaging did not detect the suspected ectopic ACTH-producing tumour in a patient with advanced Cushing's syndrome and hypokalemic alkalosis. Gamma camera examination with technetium-99m methoxyisobutylisonitrile (MIBI) depicted the tumour, which was localized in the anterior neck and mediastinum. This was later verified by surgery. 99mTc-MIBI is normally used for myocardial scintigraphy. Its accumulation is unspecific and merely reflects metabolic activity. Despite this, the present case shows that examination with this agent can provide important information with regard to tumour localization in a given situation, thereby serving as a complement to other imaging modalities. The current literature on 99mTc-MIBI for tumour diagnosis is reviewed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082672     DOI: 10.1007/bf00173046

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  32 in total

1.  99Tcm sestamibi--a new agent for parathyroid imaging.

Authors:  A J Coakley; A G Kettle; C P Wells; M J O'Doherty; R E Collins
Journal:  Nucl Med Commun       Date:  1989-11       Impact factor: 1.690

2.  Technetium-99m-MIBI and thallium-201 uptake in pulmonary actinomycosis.

Authors:  C Aktolun; D Demirel; M Kir; H Bayhan; H A Maden
Journal:  J Nucl Med       Date:  1991-07       Impact factor: 10.057

Review 3.  Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors:  E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal:  Eur J Nucl Med       Date:  1993-08

4.  Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor.

Authors:  R J Campeau; K A Kronemer; C M Sutherland
Journal:  Clin Nucl Med       Date:  1992-12       Impact factor: 7.794

5.  Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP.

Authors:  B Caner; M Kitapçl; M Unlü; G Erbengi; T Calikoğlu; T Göğüş; C Bekdik
Journal:  J Nucl Med       Date:  1992-03       Impact factor: 10.057

6.  Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study)

Authors:  R Taillefer; Y Boucher; C Potvin; R Lambert
Journal:  J Nucl Med       Date:  1992-10       Impact factor: 10.057

7.  Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison.

Authors:  L A O'Tuama; S T Treves; J N Larar; A B Packard; A J Kwan; P D Barnes; R M Scott; P M Black; J R Madsen; L C Goumnerova
Journal:  J Nucl Med       Date:  1993-07       Impact factor: 10.057

8.  Increased accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in osteosarcoma and its metastatic lymph nodes.

Authors:  B Caner; M Kitapçi; T Aras; G Erbengi; O Uğur; C Bekdik
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

9.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

10.  Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease).

Authors:  C Aktolun; H Bayhan; B Celasun; M K Kir
Journal:  Eur J Nucl Med       Date:  1991
View more
  2 in total

1.  The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies.

Authors:  David Sánchez-Martín; Angel M Cuesta; Valentina Fogal; Erkki Ruoslahti; Luis Alvarez-Vallina
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

2.  A case of Cushing's syndrome in ACTH-secreting mediastinal paraganglioma.

Authors:  H K Park; C M Park; K H Ko; M S Rim; Y I Kim; J H Hwang; S C Im; Y C Kim; K O Park
Journal:  Korean J Intern Med       Date:  2000-07       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.